Miscellaneous dermatological conditions:

Indications for QBREXZA:

Primary axillary hyperhidrosis.

Adults and Children:

<9yrs: not established. ≥9yrs: Using a single cloth, apply once daily to both axillae. Do not occlude.


Conditions that can be exacerbated by anticholinergic effect (eg, glaucoma, paralytic ileus, unstable cardiovascular status in acute hemorrhage, severe ulcerative colitis, toxic megacolon complicating ulcerative colitis, myasthenia gravis, Sjogren's syndrome).


History or presence of documented urinary retention. Monitor for urinary retention (esp. in prostatic hypertrophy or bladder-neck obstruction); discontinue immediately if develops. High ambient temperature. Advise patients to avoid use if generalized lack of sweating develops when exposed to hot/warm temperatures. Avoid other body areas, broken skin, contact with the eyes, or transfer to the periocular area. Flammable. Renal impairment. Pregnancy. Nursing mothers.

Pharmacologic Class:



Additive anticholinergic effects with other anticholinergic-containing drugs; avoid.

Adverse Reactions:

Dry mouth, mydriasis, oropharyngeal pain, headache, urinary hesitation, vision blurred, nasal dryness, dry throat/eye/skin, constipation, local skin reactions (eg, erythema, burning/stinging/pruritus).

Generic Availability:


How Supplied:

Single-use cloth—30

Pricing for QBREXZA

2.8g of 2.4% box (Qty: 1)
Appx. price $599